UNSPSC 51342601: Amidapsone

This classification denotes an antiviral agent and antimicrobial with the molecular formula C13H13N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8N5BE1I42E, chemically known as urea, (p-sulfanilylphenyl)- (8ci) but generally known as amidapsone, which bears US NIH Compound Identifier 66267. European Medicines Agency schedules Amidapsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05426MIG.

UNSPSC 51342601 Amidapsone is a Commodity code that in practice spans a narrow slice of pharmaceutical procurement — the source shows no recent state and local opportunities actually soliciting amidapsone itself. Instead, recent activity tagged to this code involves broader pharmaceutical and health-supply categories: naloxone procurement, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, direct-to-manufacturer prescription programs, and medical and first aid supplies for emergency response. The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local participants across multiple jurisdictions). This suggests the code's practical scope at state and local level extends beyond the narrow drug name to emergency pharmaceutical procurement and broader health-supply categories where pricing and distribution logistics dominate the procurement cycle.

Recent activity concentrates in Florida, Texas, Minnesota, and Oregon. Seminole County posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the contract runs two years with optional one-year renewal and includes FEMA-potential funding with federal compliance requirements. The City of Tampa issued an ITB (26P00145) on March 25, 2026, for medical and first aid supplies for the Tampa Fire Department Rescue Division, an estimated $700,000 sheltered procurement restricted to certified Small Local Business Enterprises with a 5 percent bid discount. Minnesota's MMCAP cooperative posted an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with proposals due March 26, 2026, and awards effective July 1, 2026. The Texas Health and Human Services Commission issued a Request for Information on April 3, 2026, to explore direct-to-manufacturer prescription capabilities for self-insured group health plans, signaling future formal procurement activity. The code shows mixed recent attention, driven primarily by emergency-response and cooperative-purchasing volume rather than amidapsone-specific demand.